RNAi in mice: a promising approach to decipher gene functions in vivo

Biochimie

Volumn 88, Issue 6, 2006, Pages 637-643

  Coumoul, Xavier ^a   Deng, Chu Xia ^b  

^a INSERM   (France)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Cre loxP; Fgfr2; Knockdown; Mice; RNAi

Indexed keywords

CRE RECOMBINASE; DOUBLE STRANDED RNA; RNA; RNA DIRECTED DNA POLYMERASE; SMALL INTERFERING RNA;

CLINICAL PROTOCOL; CLINICAL RESEARCH; DOWN REGULATION; EMBRYO CULTURE; EMBRYO PATTERN FORMATION; EMBRYONAL TISSUE; EMBRYONIC STEM CELL; EMBRYOTOXICITY; GENE FUNCTION; GENE TARGETING; GENETIC TRANSFORMATION; IN VIVO STUDY; KNOCKOUT GENE; LETHALITY; NONHUMAN; PERINATAL PERIOD; POSITION EFFECT VARIEGATION; PROMOTER REGION; PROTEIN INDUCTION; RNA INTERFERENCE; RNA STRUCTURE; SHORT SURVEY; STRUCTURE ANALYSIS; TRANSGENIC MOUSE; ANIMAL; CHEMISTRY; GENETICS; MOUSE; PHYSIOLOGY; REVIEW;

MAMMALIA;

ANIMALS; MICE; RNA; RNA INTERFERENCE;

EID: 33746130403     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.11.010     Document Type: Short Survey

References (77)

1. Gordon J.W., Scangos G.A., Plotkin D.J., Barbosa J.A., and Ruddle F.H. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc. Natl. Acad. Sci. USA 77 (1980) 7380-7384
2. Wolfer D.P., Crusio W.E., and Lipp H.P. Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci. 25 (2002) 336-340
3. Capecchi M. An interview with⋯Mario Capecchi. Interview by Magdalena Skipper. Nat. Rev. Genet. 6 (2005) 434
4. Capecchi M.R. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 6 (2005) 507-512
5. Deng C.X., and Xu X. Generation and analysis of Brca1 conditional knockout mice. Methods Mol. Biol. 280 (2004) 185-200
6. Austin C.P., Battey J.F., Bradley A., Bucan M., Capecchi M., Collins F.S., Dove W.F., Duyk G., Dymecki S., Eppig J.T., Grieder F.B., Heintz N., Hicks G., Insel T.R., Joyner A., Koller B.H., Lloyd K.C., Magnuson T., Moore M.W., Nagy A., Pollock J.D., Roses A.D., Sands A.T., Seed B., Skarnes W.C., Snoddy J., Soriano P., Stewart D.J., Stewart F., Stillman B., Varmus H., Varticovski L., Verma I.M., Vogt T.F., von Melchner H., Witkowski J., Woychik R.P., Wurst W., Yancopoulos G.D., Young S.G., Zambrowicz B., et al. The knockout mouse project. Nat. Genet. 36 (2004) 921-924
7. Calderon A.J., and Lavergne J.A. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential. P. R. Health Sci. J. 24 (2005) 27-33
8. Downward J. RNA interference libraries prove their worth in hunt for tumor suppressor genes. Cell 121 (2005) 813-815
9. Fountaine T.M., Wood M.J., and Wade-Martins R. Delivering RNA interference to the mammalian brain. Curr. Gene Ther. 5 (2005) 399-410
10. Wheeler D.B., Carpenter A.E., and Sabatini D.M. Cell microarrays and RNA interference chip away at gene function. Nat. Genet. 37 Suppl (2005) S25-S30
11. Guo S., and Kemphues K.J. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81 (1995) 611-620
12. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
13. Prawitt D., Brixel L., Spangenberg C., Eshkind L., Heck R., Oesch F., Zabel B., and Bockamp E. RNAi knock-down mice: an emerging technology for post-genomic functional genetics. Cytogenet. Genome Res. 105 (2004) 412-421
14. Bagasra O., and Prilliman K.R. RNA interference: the molecular immune system. J Mol Histol 35 (2004) 545-553
15. Bernstein E., and Allis C.D. RNA meets chromatin. Genes Dev. 19 (2005) 1635-1655
16. Rao M., and Sockanathan S. Molecular mechanisms of RNAi: implications for development and disease. Birth Defects Res C Embryo Today 75 (2005) 28-42
17. Collins R.E., and Cheng X. Structural domains in RNAi. FEBS Lett. 579 (2005) 5841-5849
18. Agrawal N., Dasaradhi P.V., Mohmmed A., Malhotra P., Bhatnagar R.K., and Mukherjee S.K. RNA interference: biology, mechanism, and applications. Microbiol. Mol. Biol. Rev. 67 (2003) 657-685
19. Dalmay T., Hamilton A., Rudd S., Angell S., and Baulcombe D.C. An RNA-dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus. Cell 101 (2000) 543-553
20. Lipardi C., Wei Q., and Paterson B.M. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell 107 (2001) 297-307
21. Stein P., Svoboda P., Anger M., and Schultz R.M. RNAi: mammalian oocytes do it without RNA-dependent RNA polymerase. RNA 9 (2003) 187-192
22. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
23. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., and Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20 (2001) 6877-6888
24. Elbashir S.M., Lendeckel W., and Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15 (2001) 188-200
25. Bridge A.J., Pebernard S., Ducraux A., Nicoulaz A.L., and Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34 (2003) 263-264
26. Jackson A.L., Bartz S.R., Schelter J., Kobayashi S.V., Burchard J., Mao M., Li B., Cavet G., and Linsley P.S. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21 (2003) 635-637
27. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
28. Chi J.T., Chang H.Y., Wang N.N., Chang D.S., Dunphy N., and Brown P.O. Genomewide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100 (2003) 6343-6346
29. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D.N., and Fesik S.W. Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl. Acad. Sci. USA 100 (2003) 6347-6352
30. van de Wetering M., Oving I., Muncan V., Pon Fong M.T., Brantjes H., van Leenen D., Holstege F.C., Brummelkamp T.R., Agami R., and Clevers H. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4 (2003) 609-615
31. Xia X.G., Zhou H., Ding H., Affar el B., Shi Y., and Xu Z. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acids Res. 31 (2003) e100
32. Coumoul X., Li W., Wang R.H., and Deng C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res. 32 (2004) e85
33. Coumoul X., Shukla V., Li C., Wang R.H., and Deng C.X. Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. Nucleic Acids Res. 33 (2005) e102
34. Hohjoh H. RNA interference (RNA(i)) induction with various types of synthetic oligonucleotide duplexes in cultured human cells. FEBS Lett. 521 (2002) 195-199
35. Hohjoh H. Enhancement of RNAi activity by improved siRNA duplexes. FEBS Lett. 557 (2004) 193-198
36. Yu J.Y., DeRuiter S.L., and Turner D.L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 99 (2002) 6047-6052
37. Kamath R.S., and Ahringer J. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30 (2003) 313-321
38. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperlen P., and Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421 (2003) 231-237
39. Wianny F., and Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell Biol. 2 (2000) 70-75
40. Kunath T., Gish G., Lickert H., Jones N., Pawson T., and Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat. Biotechnol. 21 (2003) 559-561
41. Lickert H., Cox B., Wehrle C., Taketo M.M., Kemler R., and Rossant J. Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos. Development 132 (2005) 2599-2609
42. Rubinson D.A., Dillon C.P., Kwiatkowski A.V., Sievers C., Yang L., Kopinja J., Rooney D.L., Ihrig M.M., McManus M.T., Gertler F.B., Scott M.L., and Van Parijs L. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33 (2003) 401-406
43. Tiscornia G., Singer O., Ikawa M., and Verma I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100 (2003) 1844-1848
44. Hemann M.T., Fridman J.S., Zilfou J.T., Hernando E., Paddison P.J., Cordon-Cardo C., Hannon G.J., and Lowe S.W. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33 (2003) 396-400
45. Liu F., Song Y., and Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6 (1999) 1258-1266
46. Wolff J.A., and Budker V. The mechanism of naked DNA uptake and expression. Adv. Genet. 54 (2005) 3-20
47. Zhang G., Budker V., and Wolff J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10 (1999) 1735-1737
48. Lewis D.L., Hagstrom J.E., Loomis A.G., Wolff J.A., and Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32 (2002) 107-108
49. McCaffrey A.P., and Kay M.A. A story of mice and men. Gene Ther. 9 (2002) 1563
50. McCaffrey A.P., Meuse L., Pham T.T., Conklin D.S., Hannon G.J., and Kay M.A. RNA interference in adult mice. Nature 418 (2002) 38-39
51. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., and Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
52. Song E., Lee S.K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P., and Lieberman J. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9 (2003) 347-351
53. Sorensen D.R., Leirdal M., and Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327 (2003) 761-766
54. Hasuwa H., Kaseda K., Einarsdottir T., and Okabe M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532 (2002) 227-230
55. Wiznerowicz M., and Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77 (2003) 8957-8961
56. Sarkar S.N., and Das H.K. Regulatory roles of presenilin-1 and nicastrin in neuronal differentiation during in vitro neurogenesis. J. Neurochem. 87 (2003) 333-343
57. Miyagishi M., and Taira K. Development and Application of siRNA Expression Vector (2002), Nucleic Acids Res Suppl 113-114
58. Miyagishi M., and Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497-500
59. Matsukura S., Jones P.A., and Taka D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31 (2003)) e77
60. Chang H.S., Lin C.H., Yu Y.C., and Chen W.C. Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown. Am. J. Pathol. 165 (2004) 1535-1541
61. Ventura A., Meissner A., Dillon C.P., McManus M., Sharp P.A., Van Parijs L., Jaenisch R., and Jacks T. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101 (2004) 10380-10385
62. Coumoul X., and Deng C.X. Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res C Embryo Today 69 (2003) 286-304
63. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., and Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93 (1996) 5860-5865
64. Xu X., Weinstein M., Li C., Naski M., Cohen R.I., Ornitz D.M., Leder P., and Deng C. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125 (1998) 753-765
65. Li C., Guo H., Xu X., Weinberg W., and Deng C.X. Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning. Dev. Dyn. 222 (2001) 471-483
66. Li X., Chen Y., Scheele S., Arman E., Haffner-Krausz R., Ekblom P., and Lonai P. Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body. J. Cell Biol. 153 (2001) 811-822
67. Nelson D.K., and Williams T. Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects. Dev. Biol. 267 (2004) 72-92
68. Weinstein M., Xu X., Ohyama K., and Deng C.X. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125 (1998) 3615-3623
69. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., and Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
70. Kioussis D., and Festenstein R. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7 (1997) 614-619
71. Frazar T.F., Weisbein J.L., Anderson S.M., Cline A.P., Garrett L.J., Felsenfeld G., Gallagher P.G., and Bodine D.M. Variegated expression from the murine band 3 (AE1) promoter in transgenic mice is associated with mRNA transcript initiation at upstream start sites and can be suppressed by the addition of the chicken beta-globin 5′ HS4 insulator element. Mol. Cell. Biol. 23 (2003) 4753-4763
72. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21 (1999) 70-71
73. Gilmore I.R., Fox S.P., Hollins A.J., Sohail M., and Akhtar S. The design and exogenous delivery of siRNA for post-transcriptional gene silencing. J. Drug Target. 12 (2004) 315-340
74. Sandy P., Ventura A., and Jacks T. Mammalian RNAi: a practical guide. Biotechniques 39 (2005) 215-224
75. Dickins R.A., Hemann M.T., Zilfou J.T., Simpson D.R., Ibarra I., Hannon G.J., and Lowe S.W. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat. Genet. 37 (2005) 1289-1295
76. Silva J.M., Li M.Z., Chang K., Ge W., Golding M.C., Rickles R.J., Siolas D., Hu G., Paddison P.J., Schlabach M.R., Sheth N., Bradshaw J., Burchard J., Kulkarni A., Cavet G., Sachidanandam R., McCombie W.R., Cleary M.A., Elledge S.J., and Hannon G.J. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 37 (2005) 1281-1288
77. Chen L., Li D., Li C., Engel A., and Deng C.X. A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33 (2003) 169-178